Literature DB >> 9794482

The V1a and V1b, but not V2, vasopressin receptor genes are expressed in the supraoptic nucleus of the rat hypothalamus, and the transcripts are essentially colocalized in the vasopressinergic magnocellular neurons.

A Hurbin1, L Boissin-Agasse, H Orcel, A Rabié, N Joux, M G Desarménien, P Richard, F C Moos.   

Abstract

We have identified and visualized the vasopressin (VP) receptors expressed by hypothalamic magnocellular neurons in supraoptic and paraventricular nuclei. To do this, we used RT-PCR on total RNA extracts from supraoptic nuclei or on single freshly dissociated supraoptic neurons, and in situ hybridization on frontal sections of hypothalamus of Wistar rats. The RT-PCR on supraoptic RNA extracts revealed that mainly V1a, but also V1b, subtypes of VP receptors are expressed from birth to adulthood. No V2 receptor messenger RNA (mRNA) was detected. Furthermore, the single-cell RT-nested PCR indicated that the V1a receptor mRNA is present in vasopressinergic magnocellular neurons. In light of these results, in situ hybridization was performed to visualize the V1a and V1b receptor mRNAs in supraoptic and paraventricular nuclei. Simultaneously, we coupled this approach to: 1) in situ hybridization detection of oxytocin or VP mRNAs; or 2) immunocytochemistry to detect the neuropeptides. This provided a way of identifying the neurons expressing perceptible amounts of V1a or V1b receptor mRNAs as vasopressinergic neurons. Here, we suggest that the autocontrol exerted specifically by VP on vasopressinergic neurons is mediated through, at least, V1a and V1b subtype receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794482     DOI: 10.1210/endo.139.11.6320

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

1.  Developmental regulation of a local positive autocontrol of supraoptic neurons.

Authors:  V Chevaleyre; G Dayanithi; F C Moos; M G Desarmenien
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

2.  Design, synthesis, and pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or oxytocin receptors.

Authors:  Maithé Corbani; Miguel Trueba; Stoytcho Stoev; Brigitte Murat; Julie Mion; Véra Boulay; Gilles Guillon; Maurice Manning
Journal:  J Med Chem       Date:  2011-03-23       Impact factor: 7.446

3.  V1a- and V2-type vasopressin receptors mediate vasopressin-induced Ca2+ responses in isolated rat supraoptic neurones.

Authors:  L Gouzénes; N Sabatier; P Richard; F C Moos; G Dayanithi
Journal:  J Physiol       Date:  1999-06-15       Impact factor: 5.182

4.  Regulation of Neuronal Activity in Hypothalamic Vasopressin Neurons.

Authors:  Toyoaki Ohbuchi; Juhee Haam; Jeffrey G Tasker
Journal:  Interdiscip Inf Sci       Date:  2015

5.  The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy.

Authors:  W S Young; J Li; S R Wersinger; M Palkovits
Journal:  Neuroscience       Date:  2006-10-04       Impact factor: 3.590

Review 6.  Role of various neurotransmitters in mediating the long-term endocrine consequences of prenatal alcohol exposure.

Authors:  Soon Lee; Irene Choi; Sang Kang; Catherine Rivier
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

7.  Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release.

Authors:  Nadia De Mota; Annabelle Reaux-Le Goazigo; Said El Messari; Nicolas Chartrel; Darren Roesch; Cynthia Dujardin; Claude Kordon; Hubert Vaudry; Françoise Moos; Catherine Llorens-Cortes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-01       Impact factor: 11.205

8.  Overlapping genes in Nalp6/PYPAF5 locus encode two V2-type vasopressin isoreceptors: angiotensin-vasopressin receptor (AVR) and non-AVR.

Authors:  Victoria L M Herrera; Pia Bagamasbad; Tamara Didishvili; Julius L Decano; Nelson Ruiz-Opazo
Journal:  Physiol Genomics       Date:  2008-04-15       Impact factor: 3.107

9.  Testing the critical window of estradiol replacement on gene expression of vasopressin, oxytocin, and their receptors, in the hypothalamus of aging female rats.

Authors:  Alexandra N Garcia; Christina K Depena; Weiling Yin; Andrea C Gore
Journal:  Mol Cell Endocrinol       Date:  2015-10-08       Impact factor: 4.102

10.  Vasopressin and v1br gene expression is increased in the hypothalamic pvn of borderline hypertensive rats.

Authors:  Bojana Savić; Andrew Martin; Andre Souza Mecawi; Zoran Bukumirić; José Antunes-Rodrigues; David Murphy; Olivera Šarenac; Nina Japundžić-Žigon
Journal:  Hypertens Res       Date:  2020-05-15       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.